Skip to content
FrontierPicks

Dormant

ZS · Zscaler, Inc.

Conviction · MEDIUM Compounder Catalyst · CybersecurityAI enterprise software

Last analysed ·

Against its published line

Nothing is through its line on this close, though 1 is sitting on its line.

How to read this

The red mark is the published kill line — the price that would prove the pick wrong. The dot is where the name closed on the last session; a dot LEFT of the mark has closed through its line.

Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row stops competing and reads well clear, with a hollow dot to say the figure is off the drawn scale. Rows run tightest first.

How a pick resolves

ZSZscaler, Inc.
$169.80
$169.80
0.0%at the line

Current thesis

Zscaler’s AI-security launch has renewed its recovery story, but faster growth remains unproven. Q1 FY27 revenue above the September 3 guidance of $935–939 million and a higher annual outlook would confirm the case; a weekly close below the September 4 market close of $169.80 would invalidate the price recovery.

Kill line

A weekly close below $169.80 invalidates the recovery above the September 4, 2026 earnings-reaction close; Q1 FY27 revenue below the September 3 guidance floor of $935 million or reduced annual revenue guidance would separately contradict growth reacceleration.

Pick status

Open commitment catalyst in 16dscored if the kill line above fires How this is scored →

Latest analysis and events for ZS —

As of 19 September 2026, the latest FrontierPicks analysis for Zscaler, Inc. (ZS): Zscaler’s AI-security launch has renewed its recovery story, but faster growth remains unproven. Q1 FY27 revenue above the September 3 guidance of $935–939 million and a higher annual outlook would confirm the case; a weekly close below the September 4 market close of $169.80 would invalidate the price recovery.

Kill line: A weekly close below $169.80 invalidates the recovery above the September 4, 2026 earnings-reaction close; Q1 FY27 revenue below the September 3 guidance floor of $935 million or reduced annual revenue guidance would separately contradict growth reacceleration.

Next dated event on file: — catalyst in 16d.

Current Thesis

Zscaler’s recovery now rests on artificial-intelligence security products lifting growth above its September guidance; revenue above the first-quarter forecast and a higher annual outlook would substantiate that case, while a weekly close below $169.80 would invalidate the price recovery.

The September 5 assessment needs revision: the adjusted September 18 close was $197.31, above the September 4 earnings-reaction close of $169.80. Zscaler also launched its agentic security operations center (SOC) on September 9, integrating models from Anthropic and OpenAI. The company announced global availability, but disclosed no product-specific revenue or annual recurring revenue (ARR) in that announcement. Commercial acceleration remains an inference. September 9 company announcement.

On the available evidence, the narrative is accelerating — the September 9 launch, September 14–15 retail-facing coverage and September 18 close show renewed attention and price recovery after the earnings disappointment. These observations do not establish broader institutional participation. The company now lists an October 6 investor day, superseding the earlier assessment that no company-dated event preceded the next quarterly results. Company event calendar, checked September 20.

Bullish and bearish views on Zscaler, Inc.

The model's bull view on Zscaler, Inc. (ZS), in brief: Quarterly demand exceeded company guidance. The bear view: The annual outlook still decelerates. On September 3, management forecast fiscal 2027 revenue of $3.908–3.938 billion, representing 16.6–17.5% growth, against 25% growth delivered in fiscal 2026. A new product headline does not itself revise that forecast. Fiscal 2026 results.… Both cases follow in full.

Bull Case

  • Quarterly demand exceeded company guidance. In its September 3 release, Zscaler reported fourth-quarter fiscal 2026 revenue of $898.2 million against guidance of $875–878 million, and net new ARR of $246 million against $166 million in the preceding quarter. These are measured results supporting the recovery case; they do not establish an acceleration beyond the annual outlook. Fiscal 2026 results.
  • Operating profitability reached a record. The September 3 release reported a fourth-quarter adjusted operating margin of 24% and fiscal 2026 free cash flow of $779.1 million. The fiscal 2027 free-cash-flow margin forecast was 23.0–23.5%, providing an explicit benchmark for subsequent results. Fiscal 2026 results.
  • The product announcement reached availability. Zscaler’s September 9 release stated that Agentic SOC was globally available, rather than describing an undated development project. Adoption and incremental revenue remain unquantified in that release. Product announcement.

Bear Case

  • The annual outlook still decelerates. On September 3, management forecast fiscal 2027 revenue of $3.908–3.938 billion, representing 16.6–17.5% growth, against 25% growth delivered in fiscal 2026. A new product headline does not itself revise that forecast. Fiscal 2026 results.
  • Acquisition effects complicate reported growth. September 3 results showed fourth-quarter ARR growth of 25%, but 20% excluding Red Canary, which contributed $141 million. Reported growth alone therefore cannot establish organic acceleration. Fiscal 2026 results.
  • Attention exceeds available positioning evidence. The supplied September 14 news list included a Zscaler price-move article, followed on September 15 by an investor-radar article and an options-activity headline. That clustering measures coverage; without underlying options direction, open interest or ownership changes, it supports no conclusion about speculative crowding.

Setup & Price Structure

The September 18 adjusted market close of $197.31 came with a three-month price increase of 59.0% and a 14-day relative strength index of 57.6. The shares remained 41.3% below their trailing annual high, according to the same dated price series. These measurements establish a recovery within a larger drawdown; they do not establish a completed long-term base.

The September 4 earnings-reaction close of $169.80 is the observable reference for this refreshed thesis. A weekly close below $169.80 would erase the recovery above that closing level and invalidate the price component of the case. Moving-average values, trading-volume comparisons and current short-interest figures are missing, so neither distance above a rising average nor a squeeze mechanism can be established.

Catalyst Calendar (next 30 days)

  • 2026-10-01 — JPMorgan Software Forum. Zscaler’s calendar lists this event within the next month. Any disclosed change to the September 3 outlook would be material; the listing itself promises no financial update. Company calendar.
  • 2026-10-06 — Zscaler Investor Day. The scheduled event provides a dated checkpoint for product economics and adoption disclosures. If it passes without quantified commercial evidence or a revised outlook, the September 9 launch remains insufficient to establish faster growth. Company calendar.

The previously estimated September 29 annual-filing event is obsolete: the September 9 product release identifies the fiscal 2026 Form 10-K as filed on September 3. The next quarterly reporting date is not confirmed in the reviewed event calendar. Company filing reference.

What Would Change Our Mind

Loss of the post-earnings recovery would break the market case: a weekly close below $169.80 would put the shares beneath their September 4 earnings-reaction close. This is a research invalidation condition tied to an observed market price.

Fundamental confirmation requires first-quarter fiscal 2027 revenue above the $939 million upper end of guidance and an increase to the $3.908–3.938 billion annual revenue outlook, both issued September 3. Revenue below the $935 million quarterly lower bound, or a reduction to annual guidance, would contradict the growth-reacceleration thesis. Until those tests resolve, the evidence supports medium conviction: the September 18 price recovery is measured, while incremental product revenue remains undisclosed. September 3 guidance.

Correlation Notes

This remains a single-company recovery thesis. The supplied September 14 headlines also described a SentinelOne rally, and September 15 coverage grouped Zscaler with CrowdStrike and other technology companies. Those articles establish overlapping attention, but the sample is too small to support a correlation claim or attribute Zscaler’s recovery to a sector-wide move.

Anthropic and OpenAI are named technology partners in the September 9 announcement. That relationship establishes product integration; the announcement supplies no revenue-sharing terms or quantified financial sensitivity to either partner. Company announcement.

Notes

  • Zscaler’s fiscal year ends July 31; fiscal-year labels therefore differ from calendar years.
  • September 3, 2026 results included $141 million of Red Canary ARR. Acquisition-inclusive and organic ARR growth are distinct measures.

Related · shared themes